Nomura Holdings
LFCR icon

Nomura Holdings’s Lifecore Biomedical LFCR Stock Holding History

Nomura Holdings’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,000
Closed -$161K – 1292
2016
Q2 		$161K Buy
+15,000
New +$165K ﹤0.01% 1066
2014
Q4 		– Sell
-18,211
Closed -$223K – 2514
2014
Q3 		$223K Buy
18,211
+3,289
+22% +$41.1K ﹤0.01% 2354
2014
Q2 		$185K Buy
+14,922
New +$176K ﹤0.01% 2413
2014
Q1 		– Sell
-21,056
Closed -$256K – 2825
2013
Q4 		$256K Sell
21,056
-19,228
-48% -$230K ﹤0.01% 1629
2013
Q3 		$492K Buy
40,284
+18,714
+87% +$261K ﹤0.01% 1406
2013
Q2 		$285K Buy
+21,570
New +$298K ﹤0.01% 1632

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Nomura Holdings's LFCR Position: Q3 2016 in Review

Nomura Holdings sold out of Lifecore Biomedical (LFCR) in Q3 2016, closing a stake of 15,000 shares — an estimated $161K sold.

Nomura Holdings first reported a position in LFCR in Q2 2013 and held it in 6 quarters. The position peaked at $492K in Q3 2013. 93 funds tracked by Wall St. Rank hold LFCR as of Q3 2016.

  • Nomura Holdings reported no remaining Lifecore Biomedical position as of Q3 2016 after selling out during the quarter.
  • Nomura Holdings sold 15,000 Lifecore Biomedical shares in Q3 2016, an estimated $161K.
  • Nomura Holdings first reported a position in Lifecore Biomedical in Q2 2013 and held it in 6 quarters.
  • Nomura Holdings's Lifecore Biomedical position peaked at $492K in Q3 2013.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2016.

Based on Nomura Holdings's 13F filing for Q3 2016, filed 14 Nov 2016.